Creating solutions to health care’s unmet needs with emerging digital and AI technologies
Founded in 2020, with a $30 million commitment, the Artificial Intelligence and Digital Innovation Fund (AIDIF) invests in venture stage companies whose offerings further Mass General Brigham’s strategic initiatives, with a keen eye on:
- Quality patient care
- Equity
- Cost reductions
- Clinician well-being
As a companion to Mass General Brigham Ventures, which focuses on accelerating breakthroughs arising from its vast internal research, the Artificial Intelligence and Digital Innovation Fund concentrates on commercial stage digital health and AI-based, externally developed digital solutions to address unmet patient needs. To date, the fund has invested in three companies.
Because digital solutions to patient care require active testing, adaptation, and roll-out across clinical environments prior to widespread use, co-development relies on health systems, such as Mass General Brigham, that can help perfect these products and define how to integrate applications into clinical workflows, thereby creating reference models for other health systems.
Improving patient care
Always on the cutting edge of care, Mass General Brigham is committed to substantially increasing the use of technology, data, and digital capabilities in the delivery and management of patient care. The system works tirelessly to increase digital innovation in every phase of care and every element of its operation. To this end, the system targets use collection and analysis of large data sets to implement break-through digital solutions.
The first fund of this type at Mass General Brigham, AIDIF works closely with the health system’s clinical, operations, research and digital leadership and Innovation’s Business Development and Licensing team to identify key areas for investment and potential co-development opportunities.
The Fund supports not only new business ventures in digital companies already partnering with Mass General Brigham but also co-development with industry, and execution of digital-based care delivery initiatives. AIDIF remains committed to advancing digital health solutions to market and accessing external collaborators and new technology.
Why AIDIF?
AIDIF brings together both venture investing and business development expertise that can add significant value to a portfolio company beyond just capital. For investment prospects that meet initial investment criteria, our team helps identify and introduce companies to relevant potential customers or co-development partners across the health system.
These connections help portfolio companies expand within the Mass General Brigham system and beyond.
AIDIF provides financial return to support Mass General Brigham’s mission. It introduces innovative solutions to our health system (both provider and payer) and captures value created when the system adopts digital solutions.
The fund is slated to make one to three co-investments per year with digital health VC investors.
Our portfolio
-
Amplifie is the leading e-learning platform helping organizations put the power of brain science to work. Mass General Brigham is using the platform to train new clinical staff to use EPIC health care software, improving clinical outcomes in a pilot program at Brigham and Women’s Hospital.
Our role: We invested in an acquisition led by Polaris Group Fund. Mass General Brigham now uses the Amplifire platform to train staff.
-
DexCare efficiently matches patients to the right clinician in the right setting at the right time. It aims to deliver care in the right way for more sustainable health system growth, enabling health systems to be more efficient.
Our role: We invested in Series A in June 2021 and Series B in December 2021 and launched the initial use for the integrated care service, part of a larger digital front-door strategy.
-
CARTA Healthcare partners with health care organizations to streamline clinical documentation and enable data-driven improvement through patient data analysis.
Our role: We invested in Series A in March 2021 and participated in Series B in November 2022. We are using Atlas, an AI-assisted data extraction for clinical registries, which leads to completing more accurate clinical registries and more value derived from data.
Let's talk
We are co-investing with strong syndicate partners, helping early commercial companies scale their technology. Is your company already working with Mass General Brigham, providing services to our system? Let’s talk about your innovation.
The Artificial Intelligence and Digital Innovation Fund
- Stage: Stage agnostic, but mainly Series A and Series B
- Initial investment: $0.5–$1.5 million in a venture-led (priced) financing round
- Strategic alignment:
- Value proposition advances Mass General Brigham’s key strategic initiative—Research and Innovation
- Externally developed digital solutions embraced by the health system to address unmet medical needs
- Product/market fit: Product offering meets a strategic stakeholder need with a contract under negotiation or signed by the time of investment
Who we are
AIDIF investment team
-
Managing Partner
Mass General Brigham Ventures -
Partner
AIDIF -
Dr. Elaine GoodmanAssistant CMIO
Mass General Brigham Venture Fellow
AIDIF Physician Leader and Digital Health
AIDIF business development team
-
Vice President, Business Development, Mass General Brigham
Venture Partner, AIDIF and Digital Health -
Associate Director, Business Development
Senior Associate, AIDIF
AIDIF governance
The AIDIF governance structure is comprised of the investment committee and the board of managers.
The AIDIF investment committee reviews AIDIF prospective investments and ensures they meet a threshold for venture capital return potential.
The board of managers is comprised of senior leadership at MGB and ensures AIDIF investments align with the health system’s strategic objectives.